US FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQS1REZ1lsNjRDTXlLYkt6T3F3bEdFcFA1UDRKdEJGX05aTFk1OE9wNjRLVHZncE1LQzg1S01PMG5kOEx5dEJoQUJHbVBmT1NDSG16NjJ2dEpFLU9TNmlWVENST0d6M2NaTnUxei1KYm9aWm9Wc0VSempseUxtd1BfN2xCZTBvdHdBYy1FT2Rzczg5X21ZTFhIT0llaDZwajRWZFFtdXdOS2pybjNzSk5oWA?oc=5" target="_blank">US FDA approves Takeda, Protagonist's drug for rare blood cancer</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMUS drug agency approves breakthrough treatment for pancreatic cancer
Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.
August 26, 2026 at 10:02 PM